Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Faecalibacterium prausnitzii is one of the main butyrate producers in the healthy human gut. Information on its genetic diversity is lacking, although two genetic phylotypes have been differentiated. In the present study,F. prausnitzii phylotypes were examined in faeces of obese and type two diabetes with similar eating behaviour compared to a lean control group. The purpose of the study was to analyse if an excessive butyrate production induced by different F. prausnitzii phylotypes discriminates between obese developing type two diabetes or not. The faecal samples were analysed for the total abundance of F. prausnitzii 16S rRNA copies, fragment lengths polymorphism, high resolution melt curve analysis (HRM) and the butyryl-CoA:acetate CoA-transferase gene copies and melt curve variances. The diabetic group was found to differ significantly from the lean control group in the results of qPCR, butyryl-CoA:acetyate CoA-transferase gene melt curve, and HRM.F. prausnitzii phylotypes differed in obese with and without developed diabetes type two. Different phylotypes of F. prausnitzii may lead to differences in the inflammatory genesis in the host.F. prausnitzii phylotypes may have an influence on developing type two diabetes and might also act as starting points for prevention and therapy of obesity associated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 5×
“F. prausnitzii belongs to the Clostridium leptum cluster, which has often been associated with T2D (Gerritsen et al. , 2011), and an negative correlation to HbA1c values (Karlsson et al. , 2013).”
InfluentialReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · cited 4×
“Therefore the BUT gene is used as a marker for butyrate production in the gut (Schwiertz et al. , 2010; Duncan et al. , 2007).”
InfluentialBrown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Moderate butyrate levels can prevent high fat-diet induced insulin insensitivity due to epigenetic regulation, increasing the mitochondrial beta oxidation, and acts so to improve glucose sensitivity and adiposity (Petersen et al., 2004).”
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
Dominant and diet-responsive groups of bacteria within the human colonic microbiota
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.118 · Cited by 1,632
Samuel, B. S., Shaito, A., Motoike, T., Rey, F. E., Backhed, F., Manchester, J. K., Hammer, R. E., Williams, S. C., Crowley, J., Yanagisawa, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808567105 · Cited by 1,564 · cited 2×
“In contrast, high-fat diets supplemented with butyrate prevent and even reverse insulin resistance in obese mice (Pegorier et al., 2004; Samuel et al., 2008).”
Claudins and the Modulation of Tight Junction Permeability
Günzel, D., & Yu, A. S. L. (2013) · Physiological Reviews · doi:10.1152/physrev.00019.2012 · Cited by 1,456
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss
Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., Mariat, D., Corthier, G., Doré, J., Henegar, C., et al. (2010) · Diabetes · doi:10.2337/db10-0253 · Cited by 1,173 · cited 4×
“prausnitzii in T2D subjects, indicating a higher incidence of low-grade inflammation (Furet et al., 2010).”
Influential
Cited by
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J., & Martinez-Medina, M. (2017) · The ISME Journal · doi:10.1038/ismej.2016.176 · Cited by 874
The interplay between diet and the gut microbiome: implications for health and disease
Ross, F. C., Patangia, D., Grimaud, G., Lavelle, A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01068-4 · Cited by 638
Profile of the gut microbiota of adults with obesity: a systematic review
Crovesy, L., Masterson, D., & Rosado, E. L. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0607-6 · Cited by 604
Faecalibacterium: a bacterial genus with promising human health applications
Martín, R., Rios-Covian, D., Huillet, E., Auger, S., Khazaal, S., Bermúdez-Humarán, L. G., Sokol, H., Chatel, J.-M., & Langella, P. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad039 · Cited by 566
Nicolucci, A. C., Hume, M. P., Martínez, I., Mayengbam, S., Walter, J., & Reimer, R. A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.055 · Cited by 516
Riva, A., Borgo, F., Lassandro, C., Verduci, E., Morace, G., Borghi, E., & Berry, D. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13463 · Cited by 426
Gut Microbiota and Intestinal Trans-Epithelial Permeability
Allam-Ndoul, B., Castonguay-Paradis, S., & Veilleux, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176402 · Cited by 351
Koh, A., & Bäckhed, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.005 · Cited by 309
Potential Role for the Gut Microbiota in Modulating Host Circadian Rhythms and Metabolic Health
Parkar, S. G., Kalsbeek, A., & Cheeseman, J. F. (2019) · Microorganisms · doi:10.3390/microorganisms7020041 · Cited by 285
“Bacteroidetes, and changes in key Firmicutes such as lowered Ruminococcaceae, Lachnospiraceae, Faecalibacterium prausnitzii, and increased Lactobacillus indicates the putative connections between bacterial diversity (and functionality) and metabolic regulation of blood glucose [7,8].”
BackgroundGanesan, K., Chung, S. K., Vanamala, J., & Xu, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123720 · Cited by 221
New Insights into the Diversity of the Genus Faecalibacterium
Benevides, L., Burman, S., Martin, R., Robert, V., Thomas, M., Miquel, S., Chain, F., Sokol, H., Bermudez-Humaran, L. G., Morrison, M., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01790 · Cited by 86
“The overall abundance of a given genospecies of Faecalibacterium within an individual host may be extremely relevant to the study of human diseases, as this overall abundance depends on the disease under study (Hippe et al., 2016; Lopez-Siles et al., 2016).”
BackgroundGut microbiome approaches to treat obesity in humans
Bianchi, F., Duque, A. L. R. F., Saad, S. M. I., & Sivieri, K. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9570-8 · Cited by 63
Metadata
- Authors
- Hippe, B., Remely, M., Aumueller, E., Pointner, A., Magnet, U., & Haslberger, A. G.
- Venue
- Beneficial Microbes
- Publisher
- Walter de Gruyter GmbH
- Published
- 2016-09-01
- Volume
- 7
- Issue
- 4
- Pages
- 511-518
- ISSN
- 1876-2883 (ISSN-L)
- 1876-2891
- OpenAlex
- W2327628890
- Cited by
- 86
- References
- 16
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.